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Abstract
Background: Lately, due to a higher incidence rate of infections, as a result of a decreased immuno-inflammatory response capacity of the human body 
and an expanded role of viral agents in triggering inflammatory diseases, the interest for the use of medical ozone has increased significantly. The reason 
for this growth of popularity lies in the fact that medical ozone has antimicrobial, antiviral, anti-inflammatory, immunomodulatory, antioxidant and 
other properties; it is not a pharmacological product, but rather a “hormetic stress” [18], a pure ecologic physico-chemical factor with multiple biological 
effects [19]. 
Conclusions: The action of medical ozone on the human body is diverse and multidirectional. The pharmacological effect of medical ozone represents 
the so-called “hormesis” phenomenon, and this effect is triggered by short chains of hydroxides – hydro-peroxides, also defined as ozone peroxides. 
Medical ozone possesses antalgic, anti-inflammatory, anti-edematous, antioxidant, myorelaxant, detoxing, immunomodulatory, antimicrobial, antiviral, 
antifungal effects, it activates the cellular metabolic processes, stimulates oxygen metabolism and improves rheological properties of blood. In dentistry, 
medical ozone is used on its own or in combination with other treatment methods. At the same time, the aspects of the use of medical ozone in clinical 
periodontology requires additional research. 
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Introduction
The action of medical ozone on the human body is 
diverse and multifaceted. In various medical fields ozone 
therapy has been applied for several decades, however 
the use of ozone in dentistry is relatively recent, since the 
middle of the 90s. Medical ozone has antalgic, anti-inflam-
matory, anti-edematous, antioxidant, myorelaxant, deto-
xing, immunomodulatory [1, 2], antimicrobian, antiviral 
and antifungal properties; it activates cellular metabolic 
processes, stimulates oxygen metabolism and improves the 
rheological properties of the blood [4, 17]. 
 The efficiency of the use of medical ozone has been 
proven and debated in the treatment of a series of systemic 
diseases, mainly of inflammatory nature, both in surgical and 
therapeutic fields [5, 6]. In comparison with the therapy with 
antibiotics, ozone therapy has a larger spectrum of therapeutic 
actions, it does not result in microbial resistance and does not 
trigger mutagenic and carcinogenic effects [7, 8]. Moreover, 
in case of the existence of microflora resistant to antibiotic 
treatment, supplementing antibiotic treatment with ozone 
therapy leads to the neutralization of antibiotic resistance and 
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dentistry, medical ozone is used on its own or in combination 
with other treatment methods [11, 12, 13].
Historical background
Ozone was mentioned for the first time by the Dutch phy-
sicist M. van Marum in 1785, who observed the formation of 
an oxidizing gas with a characteristic smell during some expe-
riments with electrical discharges. The name ozone, though, 
comes from the German chemist Friedrich Schonbein in 1840, 
who discovered for the first time the capacity of ozone to react 
with biological substrates. In 1857 the German engineer and 
inventor Werner von Siemens develops the first technical unit 
of ozone, yet in 1880, the first medical publications appear in 
America, attesting its therapeutic efficacy. The first generator 
of ozone was patented in 1896 by the physicist Nicola Tesla and 
commercialized from 1900. Subsequently, he was the first to 
ozonize olive oil for medical use. During the First World War, 
ozone was used for disinfection and treatment of plagues and 
the treatment of wounds and gangrene. In 1935 the surgeon 
Erwin Payr presents his publication of 290 pages about the 
application of ozone in surgery, while the Swiss dentist E. A. 
Fisch was the first to use ozone in dentistry and is the author 
of many publications about the use of ozone, defended his 
thesis on this theme in 1950. 
In the following years, due to Dr. J. Hansler, the first me-
dical ozone generator was created. Together with H. Wolff, 
the author of the book “Medical Ozone”, Hansler sets up the 
Medical Society for Ozone Therapy [14, 14, 16]. In 1973 the 
International Ozone Association (IOA) was created, and in 
2005 the World Federation of Ozone Therapy (WFOT).
Today, after 160 years of use, ozone therapy is recognized 
and applied in 50 countries [17].
Lately, due to the growth of the number of cases of in-
fections associated with the background of reduction of the 
immuno-inflammatory response of the body and the increase 
of the role of viral agents in the outbreak of inflammatory 
diseases, the interest in the medical use of ozone has conside-
rably increased. The reason for this growth of popularity is that 
ozone, despite having antimicrobial, antiviral, anti-inflamma-
tory, immuno-modulatory, antioxidant etc. characteristics, is 
not a pharmacologic substance, but a “hormetic stress” [18], 
an ecologically pure physico-chemical factor with multiple 
biological effects [19].
The physicochemical properties  
and biological effects of ozone
Ozone (derived from the Greek ozein, meaning “to smell”), 
is the second allotrope (active) form of oxygen – and is a gas 
of a bluish color, with a specific odor; in small quantities it 
has a pleasant “smell of purified and fresh air”, which becomes 
stingy and intensely irritating when in large proportions. 
Its molecule is made of three oxygen atoms (O3), has a 
strong affinity for the electron (1,9 eV) and has a molecular 
weight of 48.00 g/mol. In normal temperature and pressure 
conditions (0°C; 1atm=101.3kPa), the weight of one liter of 
ozone equals to 2.143g/l. One liter of air weighs 1.429g/l, re-
spectively ozone is heavier than air. The melting point of ozone 
is minus 192.5°С and it acquires a bluish-dark violet color. 
The boiling point is minus 119.9°С. The rate of dissolving of 
ozone in water is 49.4 ml/100ml (0°C; 1atm=101.3kPa), which 
is 10 times higher than the rate for oxygen [49]. The reaction 
for the production of ozone is reversible: 
3O2 + 68kcal→ 2O3
The ozone molecule is unstable and self-decomposes to 
oxygen, with emission of heat. Additionally, the life of an 
ozone molecule depends on the temperature, thus at a tem-
perature above 20°C the concentration of ozone decreases 
by half within 40 min., at 30°C in 25 min., at minus 50°C the 
concentration of ozone diminishes by half within 3 months 
[20], and at minus 78°C, in a glass recipient and certain pure 
plastic and metal recipients, ozone practically does not de-
compose [21].
The main quality which defines the specifics of the phy-
sicochemical properties is as follows:
· A high level of excess energy of the ozone molecule and
O3→³/2O2 + 34 kcal/mol
· the powerful oxidation action; the ozone is the 2-nd 
powerful oxidant, next to fluorine and persulfate [49, 22].
The ozone oxidizes all types of metals, except for gold and 
platinum. It is capable to enter in reaction with the majority 
of organic and inorganic substances. At the thermodynamic 
level, these reactions may develop up to complete oxidation, 
i.e. up to the formation of water, carbon oxides and oxides 
of other elements.
Despite its high potential for oxidation, the interaction 
pattern of ozone is very selective. The cause of this selectivity 
is the polar structure of the bond angles of the ozone molecu-
le (μ = 0,49 D) [24], more specifically the positive polarization 
of the oxygen atom, which confers electrophilic characteristics 
to the entire molecule, and due to these molecules with a high 
electronic density become its preferred reactive elements. 
The components with simple double bonds C=C enter into 
an immediate reaction, phenols and free amines are oxidized 
within a few seconds, meanwhile other substances, for exam-
ple alcohols, become oxidized within several hours.  
Of special interest are the reactions of ozone with organic 
molecules possessing double or triple bonds, which result in 
understanding the bio-chemical traits of the interaction of 
ozone with biological objects. The contact with these mo-
lecules leads to the creation of complexes and intermediate 
compounds which are less studied (zwitterione/amphyone, 
malozonyde, cyclic ozonides), which may be hydrolyzed, 
oxidized, reduced or thermally disintegrated into multiple 
substances, and mainly aldehyde, ketone, acids or alcohols 
(tab. 2) [25].
Ozone reacts with unsaturated hydrocarbons, amines, 
sulfhydryl groups, organic compounds containing sulfur 
and nitrogen, and aromatic compounds. Besides unsatura-
ted fatty acids, aromatic amino acids are also sensible to the 
action of ozone, and mainly the ones containing SH groups. 
The product of the interaction of the ozone molecule and the 
bio-organic substrates is the molecule – ozonide [26]. As a 
result of its dipolar structure, the ozone molecule may lead to 
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a 1,3-dipolar cyclo-addition of unsaturated bonds, resulting 
in the formation of a primary ozonide (I), in conformity with 
the reaction presented in fig. 1, known also as the Crigée me-
chanism (1953, 1975). Ozonation of aromatic compounds is 
similar to ozonation of olephyns with creation of polymeric 
ozonides [26].
Fig. 1.  Formation of primary ozonide.
Fig. 2.  Primary ozonide is decomposed into a carbonyl 
compound (aldehyde or ketone) and a zwitterion (II), leading to 
formation of  a hydroperoxide hydroxide (III), the stage which 
results further in decomposing into a carbonyl group[26].
Ozone may be toxic if inhaled and an irritant for the eyes. 
Inhaling by humans and mammals of ozone in higher concen-
trations may lead to its reaction with the mucous compounds 
of the airways and may result in damaging the substance whi-
ch covers the interiors of the lungs (pulmonary surfactant), 
because it has a reduced anti-oxidation capacity. Within the 
anatomopathological investigations the pattern common in 
an ozone intoxication is described as follows: blood clotting is 
disturbed, lungs are affected by a large number of hematomas 
[27]. Due to this, the maximum allowed concentration of 
ozone in the air of a working room is about 0,1 ppmv inhaled 
within one hour, which is 10 times higher than the human 
olfactory threshold (0,01 ppmv) [28]. The World Health 
Organization allows for 8 hours of work in a room in which 
the ozone concentration is 0.06 ppmv, a threshold with an 
easily-recognizable and quite powerful ozone smell [28]. 
The conversion is as follows:
1ppmv = 1.0 mcg/ml or 1.0mg/l or 1.0g/m3
Medical ozone is a product of pure oxygen (min. 99,5 %), 
created in an ozone generator, an apparatus equipped with a 
tube, in which, through an endothermic process, take place 
high voltage electrical discharges between the electrodes. 
In fact, medical ozone is a compound of oxygen and ozone 
(95% O2 - 5% O3) [37]. Medical ozone cannot be generated 
from air, due to the presence of nitrogen, which generates 
toxic nitrogen oxides [29]. Medical ozone is administered 
externally (on the skin, on the injured surface), internally (per 
os et per rectum) and parenterally, within the therapeutically 
allowed concentrations, and does not have a toxic effect on 
the human body. If used in specific conditions and for the 
treatment of specific diseases, the therapeutic efficiency of 
medical ozone is identical or similar around the world. The 
use of unsuitable administration methods and amounts, is 
the main cause of the lack of efficiency and adverse effects. 
Due to this, the medical societies advocating for the use of 
ozone have established treatment protocols, as a basis for the 
methodological standards and guidelines, which have been 
revised and published in compliance with the recent results 
of research and based on the practice in this field acquired 
during the last thirty years [29]. These were used to standar-
dize the application, indications, concentration, dosage and 
frequency of the treatment, based on the mechanism of action 
and pharmacological properties of medical ozone.
The pharmacological effect of medical ozone reflects 
the so-called hormesis phenomenon, expressed by the 
stimulatory or beneficial effect following the exposure to 
low concentration of a substance, otherwise toxic if used in 
high concentrations [30]. The concept of ozone applied in 
low doses (Low-Doze Ozone), with a moderate oxidative 
stress, becomes nowadays the ideal strategy in the field of 
ozone therapy [18].
Mechanism of action of medical ozone
Depending on the method of application, the mechanism 
of action of medical ozone may be included into two major 
categories: 
· topical use (bactericidal action, virucidal, fungicidal); 
· systemic use (regulation of the anti-oxidized cellular 
system, improved emission of oxygen by the RBC and 
immunomodulation by activating white blood cells 
(WBC);
Topical use of medical ozone in gaseous state or in the 
form of ozonized solutions, possesses anti-microbial, antiviral, 
anti-fungal effect, and the effect of cleansing and treatment 
of wounds. At the same time, it has a higher efficiency in the 
aqueous medium, because after decomposing of the ozone 
in water, a highly reactive hydroxyl radical is generated. In 
compliance with microbiological studies, ozone has the capa-
city to destroy all Gram-positive and Gram-negative known 
bacteria, including P. аeruginosa, Legionella spр, all lipid and 
hydrophilic viruses including the hepatic viruses A, B, C, HIV, 
spores and all known vegetative forms of pathogenic fungi [31, 
32]. Among the causes of the bactericidal effect of ozone, most 
frequently mentioned is the disrupting of cellular membrane 
activity of the bacteria, by oxidizing the phospholipids and 
lipoproteins, directly affecting cytoplasmic integrity. Gram-
positive bacteria are more sensitive to the action of ozone in 
comparison to Gram-negative bacteria, perhaps due to the 
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 The attention of researchers regarding the virucidal effect 
of ozone is centered on the property of the ozone to disrupt the 
multiple configurations of the lipid molecules. Indeed, if the 
external lipid membrane of the virus is dislodged, the nuclear 
DNA or RNA cannot survive. Viruses have no protection 
against the oxidizing stress, on the other hand, the normal cells 
of a mammal have the structure of complex enzymes (i.e, SOD, 
catalase, peroxidase), which neutralizes the negative effects 
triggered by the reactive oxygen species (ROS) and oxidation 
disruptions. Viruses which possess, besides nucleocapsid, 
also an external lipoproteic shell derived from the membrane 
system of the host-cell (peplos or envelope), are defined as 
enveloped viruses [34]. The enveloped viruses are much more 
sensitive to the action of the ozone, when compared to the 
non-enveloped viruses, namely due to presence of the external 
glico- and lipoprotein membrane, which interacts easily with 
ozone [35].
Although the effects of ozone on unsaturated fats repre-
sent one of the most documented biochemical actions, ozo-
ne is also known to interact with proteins, carbohydrates 
and nucleic acids. This becomes especially relevant when 
considering the effect of deactivation of non-enveloped 
viruses by ozone [36].
In order to explore the utility of ozone therapy in viral 
diseases, researchers [23] considered the possibility of action 
of ozone in vivo, because the activity of virucidal ozone be-
comes insecure when viruses are in biological fluids or, even 
worse, when they are placed intracellularly (hepatocytes, CD4 
+ lymphocytes, monocytes, glial and neuronal cells), because, 
ironically, the powerful antioxidant system of the host cell 
protects the viral integrity.
The following mechanisms may have some importance:
· A prolonged ozone treatment seems to be able to induce 
an adaptation to chronic oxidative stress (SCO), and 
therefore, a balancing of the cellular redox status, which 
is a fundamental process for inhibiting the replication 
of HIV, HBV and HCV [35, 37];
· The induction of cytokine synthesis such as interferon 
(IFN) and interleukine (IL) in ozonized blood has been 
proved possible.  Although ozone is a weak inducer, re-
infused lymphocytes and monocytes migrating through 
the lymphoid system, can activate other cells, which in 
time will lead to a stimulation of the immune system 
[38];
· Blood ozone in minor authohemotherapy (AHTm), can 
induce the oxidation of free virus components, which 
could become an inactivated and immunogen vaccine 
[38].
Certainly, ozone improves the oxygenation and the hepatic 
metabolism and it has always been confirmed that fibrinogen 
and plasma prothrombin levels have a tendency to normalize 
infected patients, thus suggesting an improvement of the hepa-
tic protein synthesis. In HIV infection, ozone therapy corrects 
acquired lipodystrophy and hyperlipidemia that accompany 
metabolic and cardiovascular complications. Cells with low 
enzymatic coverage are vulnerable to viral invasions and also 
susceptible to oxidation and elimination from the body, which 
allows their replacement with healthy cells [40].
In fungi, ozone prevents the cell growth in certain stages. 
Fungi called dermatophytes and families of fungi Candida, 
Aspergilus, Histoplasma, Actinomycoses, Cryptococcus are 
destroyed by ozone exposure. The cell walls of the fungi are 
multilayered and are composed of approximately 80% carbo-
hydrates and 10% proteins and glycoproteins. The presence of 
many disulfide connections creates the possibility of oxidative 
inactivation of fungi with ozone. Additionally, ozone is able to 
diffuse through the fungal wall into the cytoplasm and disturb 
the cell organelles. The protozoa organisms affected by ozone 
include Giardia, Cryptosporidium, Acanthamoeba, Hartmonel-
la and Negleria. The exact mechanism by which ozone exerts 
its antiprotozoal action has not been discovered yet.
 The systemic application of medical ozone through major 
authohemotherapy (AHTM) and minor authohemotherapy 
(AHTm), in the form of saline intravenous infusions or as 
of gaseous mixtures of O2/O3 in rectal or vaginal insuffla-
tions, or subcutaneous, intramuscular, para/intra articular 
injections possess analgesic, antihypoxic, antiiinflammatory, 
antiedematous, antioxidant, myorelaxant, detoxification and 
immunomodulator effects.
The following processes are activated after systemic ap-
plications of ozone to the human body:
· The activation and induction of biological antioxidants 
(scavengers) of free radicals;
· The activation of the immuno-competent cells;
· The activation of the metabolism of the red blood cells 
(RBC).
Antioxidant action. Under normal conditions of tempe-
rature and atmospheric pressure, due to its high instability 
and solubility, ozone is dissolved instantly in water and in 
biological fluids such as: plasma (90% water from the com-
position of blood plasma), the same in extracellular fluid, or 
the thin layer of water covering the skin and the respiratory 
tract, intestinal, vaginal etc. mucus. Being a strong oxidant, 
ozone reacts immediately with a number of molecules, that 
are present in biological fluids and also with antioxidants, 
proteins and carbohydrates, especially with polyunsaturated 
fatty acids (PUFAs).
Fig. 3.  Summary of the biological effects obtained  
during AHTM [26].
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The reaction of ozone with so many molecules involves 
several main processes taking place simultaneously:
· On the one hand, the ozone is inevitably consumed du-
ring oxidation of ascorbic and uric acids, sulfhydryl groups 
(SH) of a reduced glutathione (GSH), the proteins and gly-
coproteins present in the plasmatic water [43], an important 
reaction because it generates the reactive oxygen species 
(ROS), which in turn triggers a chain of biochemical reactions 
in the blood. ROS are neutralized in the first 30-60 seconds 
of the antioxidant system (SA).
· On the other hand, the reaction of lipid peroxidation takes 
place [44]. In the hydrophilic environment of the plasma, one 
mole of unsaturated olefin and one mole of ozone, lead to the 
formation of two moles of aldehyde and a mole of hydrogen 
peroxide (H2O2), [26]:
o O3 + antioxidants = ROS;
o O3 + arachidonic acid (or triglycerides and chy-
lomicrons) = H2O2 + LOPs;
These reactions, consummated within a few seconds, use 
the entire doze of ozone and generate hydrogen peroxide, whi-
ch is an oxidant and not a radical molecule (usually included 
in the ROS group) and a variety of aldehydes, known also as 
lipid oxidation products (LOPs).
Immediately after the ozone is diluted in the plasmatic 
water and reacts with the polyunsaturated fatty acids (PUFAs), 
the concentration of H2O2 starts to increase, but decreases 
equally rapidly, because this non-ionized molecule quickly 
penetrates the erythrocytes, leukocytes and platelets, acti-
vating a series of biochemical reactions and simultaneously 
is reduced by water, due to the intracellular anti-oxidizing 
enzymes: glutathione peroxidase (GSH-Px), catalase and 
GSH. This important moment corresponds to an acute and 
Fig. 4.  The reaction of ozone with isolated double bonds (Crigée 
mechanism). Hydroperoxides, in this case "ozone peroxides", are 
perceived as active pharmacological substances [18].
Fig. 5.  Situation of oxidation stress, in which the biological 
anti-oxidation system reduces the ROS. "Ozone peroxides " are 
controlled by glutathione system, and not by catalase [18].
Fig. 6.  Reaction of "ozone peroxides" with cystein (residuum) 
and (c) Glutathione [18].
Fig. 7.  "Ozone peroxides" as secondary messengers for 
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transitory controlled oxidation stress, necessary for the bio-
logical activation, which excludes any toxicity, provided that 
the used dose of ozone is compatible with the anti-oxidizing 
capacity of blood [45]. While the ROS are responsible for 
the immediate biological effects (fig. 3), LOPs are important 
due to tardive effectors, which may reach any organ, espe-
cially the bone marrow, where after binding to receptors 
in submicromolar concentration, determines adaptation to 
repeated acute oxidation stress, a typical feature of the ozone 
autohaemotherapy [38]. Given its transitory presence in the 
cytoplasm, H2O2 (generated by ozone) acts as a chemical mes-
senger of the ozone. Currently, the H2O2 is largely recognized 
as an intracellular signaling molecule, capable of activating 
the tyrosine-kinase, which phosphorylates the nuclear tran-
scription factor - kB (NF-kB), allowing for the synthesis of a 
various number of proteins [46].
Practically, the H2O2 functions by oxidizing the cysteine 
[47], which on its turn influences the mononuclear blood 
cells [48], platelets, endothelial cells [50] and the erythro-
cytes [28, 51]. Once inside the cell, the H2O2 molecules are 
almost immediately reduced to water and/or lipoperoxides 
to hydro-peroxides. 
Hydroperoxides or "Ozone peroxides", a term proposed by 
several authors [28] assume the role of physiologically active 
ozone metabolites. Due to selective reaction of ozone with the 
double bonds C = C of essential fatty acids, the classic ozonolysis 
described by Criegée (fig. 4) becomes the dominant reaction 
present in physiological conditions with the pH values ≤7,4. 
The ozonolysis lasts only fractions of a second, and forms 
mainly short chains of hydroxi-hydroperoxides in a aqueous 
medium (ozone peroxides), which are obviously responsible 
for the pharmacological effect during the systemic treatment 
with medical ozone.
Ozone peroxides are reactive oxygen compounds, asso-
ciated with the membranes, which act as second messengers 
through the residuum of cysteine and/or through reduced 
levels of glutathione (GSH), in a less aggressive manner com-
pared to the superoxide radicals ·O-O− and the H2O2 and are 
taking over the anti-oxidating regulation, without the need of 
SOD and catalase, similar to the oxidation stress developed as 
a result of relevant pathological conditions (fig. 5, 6).
Short chains of Hydroxi-hydroperoxide with a tendency 
to low radical reactions may result in initiating regulation of 
the anti-oxidizing protective mechanisms, as a signal for redox 
(e. g., through the nuclear factor Nrf2 into stress and through the 
nuclear factor NFkB into inflammatory processes (fig. 7) [18].
Processes for oxidating the residuum of cysteine and gluta-
thione induce regulation of cytokines and of the anti-oxidation 
system through NFkB, and respectively through Nrf2 [18].
During a lengthy treatment, the activity of LOPs shall 
culminate in the regulation of antioxidation enzymes, gene-
ration of oxidative stress proteins (OSP) (heme oxygenase 1, 
a typical marker) and probably the release of a stem cell, the 
essential factors which explain some of the extraordinary 
effects of ozone therapy.
The therapeutic response obtained after the repeated 
oxidative stresses suggests a preconditioned effect, eventu-
ally capable of restoring the balance of the oxido-reducing 
tissue system, which has been modified through pathogenic 
factors [28].
Immunomodulatory action. Presently, the immunomo-
dulatory effects of ozone therapy are related to induction of 
cytokine by the lymphocytes and monocytes [38], such as 
interferons (IFN) B and gama, interleukins (IL) 1B, 2, 4, 6, 8 
and 10, the tumor necrosis factor (TNFx) and growth factors 
GM-CSF (granulocyte-macrophage colony-stimulating fac-
tor), TGFβ1 (transforming growth factor beta 1) [52], PDGF 
(platelet-derived growth factors), bFGF (the basic fibroblast 
growth factor), EGF (epidermal growth factor), KGF (ke-
ratinocyte growth factor), thus promoting the synthesis of 
intracellular matrix and the healing process (fig. 9) [53, 54, 
55, 56]. It is possible that these cytokines also activate other 
lymphoid cells, which leads to immunostimulation without 
adverse effects [57, 58]. 
At the same time, the influence of ozone on the phagocyte 
activity of leukocytes is being studied. Therapy with medical 
ozone modulates all the dislodged stages of phagocytosis and 
contributes to rapid elimination of inflammatory processes 
[59]. Firstly, the time of adherence to the surface of a phago-
cyte is reduced (PMN, macrophage) and secondly, the stage of 
respiratory explosion becomes specifically pronounced, being 
determined by the generation of peroxides. Another possible 
modality for phagocyte activation is the increased synthesis 
of the phagocyte stimulation factor [60].
Hemorheological action. Erythrocytes contain a large 
reservoir of GSH (approximately 1 mmol / l), thioredoxin with 
two available cysteines and powerful antioxidant enzymes 
(catalase, GSH-Rd, GSH-Px, GSH-Tr and SOD). They may 
neutralize quickly large quantities of oxidants, such as OH, 
H2O2, OCl-, ONOO-  and at the same time may recycle back the 
oxidized compounds [61]. In the erythrocytes, the activation 
of the oxygen dependent processes are manifested through 
the increased activity of the glutathione system [4, 38]. Oxi-
dation of sulfhydryl groups (–SH) results in accumulation of 
oxidized state of glutathione (GSSG) with the modification 
of the reduced and oxidized GSH [62], which leads to the use 
of nicotinamide adenine dinucleotide phosphate, in reduced 
form (NADPH), for recycling of oxidized glutathione (GSSG) 
at the initial GSH level.  NADPH is a coenzyme which ser-
ves as an electron donor for various biochemical reactions; 
additionally the NADPH regenerates also other intracellular 
antioxidants, especially vitamin E and ascorbic acid [60]. In 
its turn, the NADP, in its oxidized state is reduced after acti-
vation of the pentose phosphate pathway, a reaction in which 
the glucose-6-phosphate dehydrogenase (G-6PD) is the key 
enzyme, leading to an increased glycolysis (fig. 8) [38].
Thus, ozone therapy stimulates oxygen metabolism by 
increasing glycolysis in red cells (fig. 9). On the one hand, 
this leads to activation of 2,3 diphosphoglycerate (2,3DPG), 
which in its turn results in an increased quantity of oxygen 
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released by the oxyhemoglobin to the tissues, which result in 
improved oxygen levels in tissues:
HbO2 + 2,3 – DFG = Hb 2,3 – DFG + O2.
Increased consumption of oxygen by the body has been 
proven by special measurement methods of the gases contai-
ned in blood. The clearest confirmation was the proof of an 
increased arteriovenous oxygen difference [63]. The partial 
pressure of oxygen contained in the venous blood, after fol-
lowing a session of ozone therapy, diminishes from 40 mm Hg 
to 20 mm Hg or even less [60, 64], which means that ozone 
therapy ensures an increased release of oxygen into the tissues 
with an insufficient blood supply – an effect impossible to 
obtain by medication [65, 66].
On the other hand, the increased levels of glycolysis result 
in activating the Krebs cycle (the aerobe pathway) by increa-
sing the production of the adenosine triphosphate (ATP). 
The decreased level of the plasma glucose in vitro has been 
demonstrated by a series of studies [62], and this is especially 
clear in cases of patients with diabetes [67].
In the process of ozone therapy, the saturation with 
oxygen of both plasma and erythrocytes takes place. In the 
presence of ozone, blood is capable to absorb up to 2-10 
times more oxygen than normally [68]. At the same time, 
it becomes possible to maintain the exchange of substances 
through the intracellular liquid, in conditions of a disturbed 
vascular tone. All patients who were treated with ozone 
in the form of AHTM presented a statistically significant 
increased level of partial oxygen pressure in arterial blood, 
a decreased partial pressure of carbon dioxide and a raised 
level of oxyhemoglobin [68]. After concluding the treat-
ment, the maximum time for reduction of oxyhemoglobin 
decreases very slowly, more precisely within a period of 
several weeks and even months. 
It seems obvious that erythrocytes may be modified by 
ozone therapy only for a short period of time. However, the 
repeated therapeutic administrations may allow for the LOPs 
compounds to permeate the bone marrow and activate the 
subtle development of an erythropoietic level, favoring ge-
neration of “super-gifted erythrocytes” – new erythrocytes 
with improved biochemical properties [61]. Based on this 
hypothesis, due to extended ozone therapy, the bone marrow 
may release a group (approximately 0,9% of the total fund) of 
new erythrocytes with improved biochemical properties. In 
fact, the therapeutic benefits do not cease once the treatment 
is stopped, but rather continue to exist for up to 2-3 months, 
perhaps in correlation with the life span of circulating su-
per-gifted erythrocytes. It has been demonstrated that after 
an extended period of treatment with ozone, the fraction of 
young erythrocytes, isolated by the old erythrocytes [69] by 
separation in density degree, had a much higher content of 
G6PD (Glucose-6-phosphate dehydrogenase) [61]. Activati-
on of metabolic processes in the erythrocytes contributes to 
accumulation of macro energetic compounds ATP [70]. As a 
result, the transportation function of the cellular membrane 
is intensified, by activation of ionic pumps ATP-ase Na+ - K+ 
and, subsequently, the concentration of intracellular cations 
(K +) and extracellular cations (Na +), the level of resting 
potential of the membrane and distribution of electrical 
charges are regulated, and thus the activity of adhesion and 
aggregation of cells is modified, which determines the rheo-
logical properties of blood.  Additionally, the generation of a 
lipid bilayer of peroxides diminished the viscosity of the lipid 
bilayer membrane, leading in turn to an improved flexibility 
and elasticity (capacity to deform) of erythrocytes [60].
ROS and LOPs are responsible for the increase of the 
function of erythrocytes [26], and also for the activation 
of leucocytes [38], platelets and endothelial cells [50]. This 
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multi-faceted and simultaneous activation results in a boos-
ted release of nitric oxide (NO), prostacyclin (through the 
selective reaction with the double bonds of arachidonic acid, 
by launching its metabolism), adenosine [71], autacoid and 
contributes to an improved tissue vascularization [72]. Indeed, 
through the interaction with the endothelium, the LOPs result 
in a boosted generation of NO and NO-tiol, which shall result 
in turn in an increased oxygen input, thus improving the mi-
crocirculation. Moreover, the phenomenon of adaptation to 
chronic oxidative stress implies the fact that repeated ozone 
treatments induce the synthesis of the oxidative stress prote-
ins, of which the HO-1 (hemo-oxigenase) serves as a primary 
example. This enzyme induces a boosted level of bilirubin (a 
lipophilic antioxidant equally powerful to tocopherol) and 
CO. The enzyme reduces indirectly the vasoconstriction, due 
to suppression of the endotheline-1 genes and inhibits the 
proliferation of smooth muscle cells [73]. It is a known fact 
that the NO, the release of which is boosted by ozone therapy 
[72], is the most important physiological vasodilator and in-
hibitor of platelet and leukocyte aggregation and of adhesion 
to endothelium, which in cooperation with certain traces of 
CO increases vascular relaxation [38].
The performed studies on ozone therapy effects on hema-
tologic/hemodynamic parameters attest that the treatment 
with medical ozone, practically, does not modify any levels 
of the methemoglobin, neither hematocrit levels, because of 
the absence of any changes in the RBC volume, caused by an 
edema or lysis, but actively influences the active blood clotting 
system. The diminished blood and plasmatic viscosity is due 
to the decreased fibrinogen levels [51].
Fibrinogen is the primary factor for clotting, having the 
biological property to clot under the influence of the specific 
enzyme – thrombin. The product of this reaction - fibrin, 
forms the reticular basis of the thrombus, which clogs up 
the affected vessel. Fibrinogen plays an important role in the 
aggregation of erythrocytes and platelets [74]. The increase 
of the concentration of fibrinogen causes an increase of the 
viscosity of the blood [75]. Therefore, medical ozone, applied 
in low concentrations, by reducing the concentration of fibri-
nogen, lowers the aggregation of blood cells and ameliorates 
the rheological properties of the blood [76]. 
The activation of the fibrinolytic mechanism in the hemo-
stasis system prevents the development of blood clots, resul-
ting in partial or total thrombosis, leading in its turn to the 
fibrinolysis and ensures its elimination from the vascular bed. 
This is one of the primary mechanisms of revascularization 
and restoring of the blood flow to the organs and tissues [75].
In high concentration, medical ozone, used only for ex-
ternal applications, has a pronounced hemostatic effect [38].
Therefore, not the ozone itself, but ROS (largely H2O2) 
and LOPs are responsible for the succeeding and multiple 
biochemical reactions which take place in various cells thro-
ughout the body. [38].
Use of medical ozone in dentistry
Normally, the oral cavity hosts about 20g commensal 
bacteria which are better kept under control by the lymphoid 
tissue related to the mucous (MALT). However, they can be-
come pathogenic and are largely responsible for tooth decay, 
which is reported by the Dr. E. Fisch (1899-1966), considered 
the first dentist to use ozone in his practice and to demonstrate 
Fig. 9.  The three pharmacological effects of medical ozone obtained through peroxides generated by ozone: (1) Improved release  
of oxygen to the red blood cells (RBC); (2) Immunomodulation through the activation of white blood cells (WBC) and (3)  
Regulation of the cellular anti-oxidation system [18].
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the potential of ozone disinfection activity [38]. Nowadays, 
medical ozone in dentistry is applied as a complementary 
treatment or in combination with other methods of ozone 
therapy [13]. The most frequently used in dentistry and Oral 
& Maxillofacial surgery (OMS) are the ozonized solutions [77, 
78, 79, 80, 81, 82]. At the 15th World Congress organized by 
the International Ozone Association (IOA, 2001) it was re-
ported that application of ozonized water in oral cavity heals 
the wounds more speedily compared to placebo treatment. 
In dentistry the ozonized distilled water is used for cleaning 
up the oral cavity, antiseptic irrigation of canals and caries. 
The ozonized water jet fully removes the purulent material 
and disinfects the affected area [83]. The use of ozone in 
combination with the dental scaling and professional teeth 
brushing allows a considerable improvement of oral hygiene 
and periodontal indices [84, 85].
Although the direct use of ozone in the gaseous form 
is prohibited (toxic by inhalation), A. Baysan and E. Lynch 
successfully used a new system of delivering ozone to treat 
primary root carious lesions (PRCL), capable of avoiding any 
toxic risk. This system includes a source of medical ozone 
and a manual dental instrument, on the end of which is fixed 
a detachable silicone suction cup. Due to its elastic edge, it 
is sealed to the tooth surface and allows the exposure of the 
carious lesion to gas. The exposure to ozone for a period of 
10-20 seconds, with a concentration of ozone (about 4 mcg / 
ml) and a gas flow rate of 600 ml / min is enough to destroy 
all the microorganisms present in the primary root carious 
lesions. In this case, the most important is to achieve the 
denaturation of protein and killing the lactobacilli which, 
following the metabolism of glucose, may result in generation 
of lactic acid, which in turn favors further demineralization 
of the dental enamel. The effect of rapid dental surface ste-
rilization by ozone is maintained for about an hour, enough 
time for the enamel remineralization by calcium phosphate 
which is present in saliva, thus the tooth becoming stronger 
and more resistant to bacterial attacks for a period of three 
months, to the least [86].
The antimicrobial properties of medical ozone, when used 
for reducing the number of cariogenic bacteria, are also the 
cause of a significant reduction of microorganisms that are 
present in BP. From the prospective of a potential antibacterial 
agent, ozonized water, in most conditions presents less cyto-
toxicity than ozone gas or recognized antimicrobial agents 
such as chlorhexidine digluconate, sodium hypochlorite or 
hydrogen peroxide. As a result, the ozonized water meets the 
optimal cellular biological requirements regarding biocom-
patibility in oral application [87].
Some authors recommend complementing OMS methods 
with ozone therapy. The use of ozone in the pre- and post-sur-
gery allowed for a considerable improvement in postoperative 
evolution, an acceleration of the operation wound epitheli-
alization and a decreased time of antibiotics administration 
[88]. In OMS, ozonized solutions are used locally for treating 
purulent inflammatory processes (periostitis, alveolitis, 
phlegmon) [89, 78], in open fractures of the mandible and in 
posttraumatic prophylaxis of inflammatory complications. 
Ozone has a beneficial influence on metabolism and bone 
restorative processes [91]. It has been noticed that in patients 
with chronic osteomyelitis of the jaw, the use of medical ozone 
normalizes quickly and completely the non-specific resistance 
and T-cell immunity, thus accelerating the healing process and 
reducing the incidence of clinical complications [92].
The relevancy of applying ozone therapy in inflammatory 
processes in the oral & maxillofacial region is determined by 
the spread of antibiotics resistant forms of microorganisms 
and the change of the patient’s sensibility to this reaction. 
Several authors mention the necessity of systemic application 
of ozone therapy, by pleading the immunomodulatory action 
of medical ozone, which reduces the period of exudation from 
the wound, accelerates the emergence of the granulation and 
wounds epithelialization to the patients with phlegmons with 
torpid evolution in the oral & maxillofacial region [88].
Medical ozone is very effective in endodontics, except 
one must ensure the correct application of ozone and na-
mely: sufficient concentration, suitable time and the correct 
method of application in the radicular channels, and cer-
tainly, after the procedures of preparation, irrigation and 
traditional endodontic cleaning have been completed. The 
studies have demonstrated the potential of using ozone as 
gas, ozonized water and oil in endodontic therapy. The ozo-
nized water can be used as a final syringe in combination 
with a ultrasonic apparatus, that produces a very effective 
“streaming” sound, allowing ozonized water to penetrate 
many parts of the intra-radicular anatomy, much more effi-
cient than conventional obturation techniques [93].The use 
of ozone in prevention of peri-implantitis is motivated by 
ensuring a proper diet and regular control of the bacterial 
plaque, and additionally, the use of ozone shows a positive 
healing of wounds due to an increased blood circulation in 
the tissue. Also, of interest are communications concerning 
the application in the CMF of ozonated oils, especially in 
cases of alveolitis [89]. The authors attest the reduction 
of the healing process in comparison with the traditional 
therapy duration. In cases of inflammatory diseases of the 
treatment resistant mucous tissues (i.e. relapsed herpetic 
stomatitis etc), some authors recommend the combination 
of the local ozone therapy with the systemic one.  Such a 
treatment scheme allows for the achievement of a stable 
remission in short term for most patients [94].
The possibility of using ozone as a local antiseptic in treat-
ment of odontogenic purulent sinusitis is of interest likewise. 
According to studies, ozone therapy is the most effective 
method when compared to other treatment methods. In case 
of emphasized intoxication syndrome, which complicates the 
development of sinusitis, the combination of systemic and 
local ozone therapy is recommended. This allows for rapid 
normalization of biochemical blood indicators [95].
Thus, ozone therapy experienced a boosted application 
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The ozone acts on several pathogenic links of the periodontal 
disease, firstly by regulating the system of antioxidants (SA), 
and secondly by improved oxygen supply and reduction of 
healing time of periodontal tissues. Certainly, its bactericidal 
and immunomodulatory abilities are of major importance. 
In treatment of the periodontal disease, the medical ozone 
is locally applied into periodontal pockets (PPr), in the form 
of instillations, solutions or oil drips, and possess a proven 
anti-inflammatory potential, based on the analysis of objective 
diagnostic criteria [3, 90, 96, 97, 98].
Conclusions
The ozone molecule is unstable and breaks down into 
oxygen, succeeded by an exothermic reaction. The basic 
quality which defines the specifics of the physicochemical pro-
perties is the high level of excess energy of the ozone molecule 
and its strong oxidizing action. The pharmacological effect of 
medical ozone is represented by the so-called hormesis pheno-
menon, expressed through the stimulatory or beneficial effect 
following the exposure to low concentrations of a substance, 
otherwise toxic in higher concentrations, and this effect takes 
place due to the short chains of hydroxyl-hydro-peroxide, the 
so-called ozone peroxide.  The mechanism of action of me-
dical ozone is divided into two major categories, depending 
on the application method: topical or systemic application. 
The action of medical ozone action on the human body is 
diverse and multidirectional. The medical ozone possesses 
analgesic, anti-inflammatory, anti-edematous, antioxidant, 
muscle relaxant, detoxing, immunomodulatory, antimicrobial, 
antiviral, antifungal effects, it activates cellular metabolic 
processes, stimulates oxygen metabolism and improves the 
rheological properties of the blood. Ozone therapy is a highly 
effective method for treating many diseases, of which the 
pathogenesis of the inflammatory syndrome is based on the 
bacterial etiology and immuno-inflammatory response of the 
host. At the same time, unlike antibiotic therapy, ozone has a 
much broader spectrum of therapeutic action, does not create 
any microbial resistance and has no adverse effects. Medical 
ozone in dentistry is used in monotherapy or combined with 
other treatment methods. Meanwhile, the other aspects of 
the use of medical ozone in clinical periodontology requires 
additional research.
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Abstract
Background: The skin is a major actor of human homeostasis mainly due to its important role in body temperature regulation but also through its role 
of barrier against any external aggression, and as a transmitter of a lot of information to the brain. It is very important that this vital organ can regulate its 
own homeostasis to be able to assume its role for the rest of human body. It is commonly admitted that cutaneous homeostasis is more or less the barrier 
effect but the last discovery for the last decade opens new interesting fields of investigation. Degradation of tight junctions with age are well-known.  In 
rosacea, the water permeation in epidermis sever the cells and break the junctions, it is an open door for microbial infections and dramatic dryness. On 
atopic mice skin model, Yokushi and al. showed in 2015 that tight junctions of atopic skin are more permeable and this is correlated with the filaggrin 
protein depletion. If junctions still stop microbials and big molecules penetration, they let small molecules under 30 KDalton to penetrate the epidermis. 
This could be one of the causes of the inflammatory status of atopic skins and of dryness as water permeation is increased as well.
Conclusions: In conclusion, skin homeostasis becomes more and more complex with the last discoveries about skin microbiota. Interactions between 
sebum, epidermal lipids, epidermal peptides and microbiota are huge. We have an open field to innovate in new treatment taking into account the 
capability of billions of living cells on our skin surface which talk with our cells all the time and work together to help our skin assume its defense role 
of the human body.
Key words: cutaneous homeostasis development.
Introduction
The skin is a major actor of human homeostasis mainly 
due to its important role in body temperature regulation but 
also through its role of barrier against any external aggression, 
and as a transmitter of a lot of information to the brain. 
It is very important that this vital organ can regulate its 
own homeostasis to be able to assume its role for the rest 
of human body. It is commonly admitted that cutaneous 
homeostasis is more or less the barrier effect but the last 
discovery for the last decade opens new interesting fields of 
investigation.
We will study some of the last developments about 4 skin 
homeostasis mechanisms:
1. Cell cohesion.
2. The stratum corneum lipids and peptides.
3. The hydrolipidic film.
4. Skin microbiota.
Reminder on cell cohesion
From the basal layer to the stratum corneum, keratinocytes 
are hung together through tight junctions. Hemi-desmosomes 
hang cells to the dermis, desmosomes hang keratinocytes 
together, corneo-desmosomes give sealing to corneocytes 
until desquamation.
Physiology status
By hanging cells together very tightly, junctions filter the 
entry of external agents and avoid infections and irritation. In 
